Tech Company Financing Transactions

Generate Biomedicines Funding Round

Generate Biomedicines secured a $370 million Series B funding round on 11/22/2021. Backers included Alaska Permanent Fund, Altitude Life Science Ventures and Arch Venture Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
With this current round of funding, Generate Biomedicines plans to scale up its workforce to 500 -- the company has 80 employees at the moment.

Company Information

Company Status
Private & Independent
Mailing Address
26 Landsdowne St.
Cambridge, MA 02139
Email Address
Founded in 2018 by Flagship Pioneering, Generate Biomedicines is the latest in a long line of unprecedented multi-product platform companies like Moderna Therapeutics, Rubius Therapeutics, Indigo Agriculture, and Sana Biotechnology. These companies have pioneered breakthroughs in a variety of life sciences fields.
Generate Biomedicines LinkedIn Company Profile
Social Media
Generate Biomedicines Company Twitter Account
Company News
Generate Biomedicines News
Generate Biomedicines on Facebook
Generate Biomedicines on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Nally
  Michael Nally LinkedIn Profile  Michael Nally Twitter Account  Michael Nally News  Michael Nally on Facebook
Chief Scientific Officer
Michael Nohaile
  Michael Nohaile LinkedIn Profile  Michael Nohaile Twitter Account  Michael Nohaile News  Michael Nohaile on Facebook
Chief Technical Officer
Gevorg Grigoryan
  Gevorg Grigoryan LinkedIn Profile  Gevorg Grigoryan Twitter Account  Gevorg Grigoryan News  Gevorg Grigoryan on Facebook
Vice President
Kristen Hopson
  Kristen Hopson LinkedIn Profile  Kristen Hopson Twitter Account  Kristen Hopson News  Kristen Hopson on Facebook
Vice President
Adam Root
  Adam Root LinkedIn Profile  Adam Root Twitter Account  Adam Root News  Adam Root on Facebook
VP - Bus. Development
Molly Gibson
  Molly Gibson LinkedIn Profile  Molly Gibson Twitter Account  Molly Gibson News  Molly Gibson on Facebook



Browse more venture capital transactions:

Prev: 11/22/2021: SnapAttack venture capital transaction
Next: 11/22/2021: Benchling venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary